Innovations in Clinical Trial DesignErica Tennenhouse, PhD | September 4, 2020 Matthew M. Laughon, MD, MPH is a professor at the University of North Carolina (UNC) at Chapel Hill in thedepartment of pediatrics.
Faster Turnaround Times and Other Advances in Precision MedicineErica Tennenhouse, PhD | July 9, 2020 New technologies are allowing physicians to make timely decisions for cancer patients
Breaking Down SARS CoV-2 Antibody TestingErica Tennenhouse, PhD | May 7, 2020 A conversation with Dara Wright, executive vice president and president of the clinical diagnostics group at Bio-Rad
Ask the Expert: Cancer and the MicrobiomeLaura M. Bolt, PhD | May 1, 2020 Clinical Lab Manager talks with Sandrine Miller-Montgomery, PharmD, PhD, about microbiome research and its applications in cancer research
Meeting the Critical Demand for COVID-19 TestsErica Tennenhouse, PhD | April 10, 2020 A conversation with Dave Hickey, worldwide president of integrated diagnostic solutions at BD
A Point-of-Care CRISPR-based COVID-19 Diagnostic on the HorizonAnna MacDonald | April 1, 2020 Rapid and early detection of SARS-CoV-2 plays a crucial role in facilitating early intervention and treatment and preventing disease spread
Time to Transition to Clinical Lab 2.0Erica Tennenhouse, PhD | February 25, 2020 Clinical Lab 2.0 is a movement that provokes the lab industry to view itself through a new value lens aligned with the forces driving the future of value-based health care
Experiences in Clinical Lab AutomationLaura M. Bolt, PhD | November 30, 2019 Going automated can be a lengthy process, but patients ultimately benefit
Blueprints for Antimicrobial StewardshipErica Tennenhouse, PhD | August 31, 2019 Antibiotic stewardship should be a priority for all patient-facing clinicians
From Sick Care to Well CareClinical Lab Manager | July 22, 2019 How healthcare is primed for disruption
The Promise of CRISPR-Based DiagnosticsLaura M. Bolt, PhD | May 31, 2019 A conversation with Janice Chen, PhD, the co-founder and chief research officer of Mammoth Biosciences
Boosting the Clinical Utility of Liquid BiopsyMasha G. Savelieff, PhD | March 31, 2019 A conversation with Maximilian Diehn, MD, PhD, associate professor of radiation oncology at Stanford University
Advances in Cell-Free DNA for Prenatal ScreeningMasha G. Savelieff, PhD | December 1, 2018 A conversation with Megan Allyse, PhD, assistant professor of biomedical ethics at Mayo Clinic
The Next Frontier in 3-D Bioprinting and Tissue EngineeringTanuja Koppal, PhD | October 19, 2018 Anthony Atala, MD, discusses some of the exciting possibilities as well as existing challenges in 3-D bioprinting
Experiences in Clinical Lab AutomationLaura M. Bolt, PhD | October 10, 2018 Going automated can be a lengthy process, but patients ultimately benefit
Trends in Clinical GenomicsTanuja Koppal, PhD | September 12, 2018 George Miles, MD, PhD shares some details on his work in clinical genomics